Literature DB >> 7837881

Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance.

J Emmerich, O Poirier, A Evans, P Marques-Vidal, D Arveiler, G Luc, M Aiach, F Cambien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7837881

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Homozygosity for factor V Leiden mutation and ischemic stroke: two case-reports and review of the literature.

Authors:  Achim Allroggen; Ralf Dittrich; Martin Ritter; Rainer Dziewas; Ralf Junker; Darius G Nabavi
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

2.  Increased rate of factor V Leiden mutation in patients with cerebral venous thrombosis.

Authors:  M Weih; B Vetter; S Ziemer; S Mehraein; J M Valdueza; J Koscielny; A E Kulozik; K M Einhäupl
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

3.  Cerebral venous thrombosis and activated protein C resistance.

Authors:  M Sánchez del Rio; E Gómez-Tortosa; J Outeriño
Journal:  J Neurol       Date:  1996-10       Impact factor: 4.849

4.  Plasma resistance to activated protein C regulates the activation of coagulation induced by thrombolysis in patients with ischaemic heart disease.

Authors:  O D Pedersen; J Gram; J Jespersen
Journal:  Heart       Date:  1997-02       Impact factor: 5.994

5.  Evidence against heterozygous coagulation factor V 1691 G-->A mutation with resistance to activated protein C being a risk factor for coronary artery disease and myocardial infarction.

Authors:  W Prohaska; H Mannebach; M Schmidt; U Gleichmann; K Kleesiek
Journal:  J Mol Med (Berl)       Date:  1995-10       Impact factor: 4.599

6.  Correlation with Platelet Parameters and Genetic Markers of Thrombophilia Panel (Factor II g.20210G>A, Factor V Leiden, MTHFR (C677T, A1298C), PAI-1, β-Fibrinogen, Factor XIIIA (V34L), Glycoprotein IIIa (L33P)) in Ischemic Strokes.

Authors:  Sener Tasdemir; Haktan Bagis Erdem; Ibrahim Sahin; Lutfi Ozel; Gokhan Ozdemir; Recep Eroz; Abdulgani Tatar
Journal:  Neuromolecular Med       Date:  2016-03-07       Impact factor: 3.843

7.  Prevalence of factor V Leiden (APCR) and other inherited thrombophilias in young patients with myocardial infarction and normal coronary arteries.

Authors:  A Dacosta; B Tardy-Poncet; K Isaaz; A Cerisier; P Mismetti; S Simitsidis; J Reynaud; B Tardy; M Piot; H Decousus; D Guyotat
Journal:  Heart       Date:  1998-10       Impact factor: 5.994

8.  Combination of factor V Leiden and MTHFR mutations in myocardial infarction.

Authors:  Najiba Fekih-Mrissa; Dhouha Berredjeb-Benslama; Abdeddayem Haggui; Habib Haouala; Nasreddine Gritli
Journal:  Ann Saudi Med       Date:  2012-07-01       Impact factor: 1.526

9.  Factor VLeiden and prothrombin G20210A gene polymorphisms in patients with coronary artery disease.

Authors:  Bahadir Ercan; Lülüfer Tamer; Nehir Sucu; Hasan Pekdemir; Ahmet Camsari; Uğur Atik
Journal:  Yonsei Med J       Date:  2008-04-30       Impact factor: 2.759
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.